Trial Profile
A Phase I Single Blinded Randomised Exploratory Trial in Elderly Volunteers to Assess and Compare Safety and Immunogenicity of Adjuvanted Seasonal Influenza Vaccine (Investigational Vaccine) to Standard Seasonal Influenza Vaccine.
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 04 Oct 2011
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary) ; Matrix M (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors Novavax AB
- 04 Oct 2011 New trial record